HI
RDY icon

HBK Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

HBK Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-30,000
Closed -$241K – 1004
2017
Q1 		$241K Buy
+30,000
New +$259K ﹤0.01% 611
2015
Q2 		– Sell
-36,000
Closed -$411K – 1068
2015
Q1 		$411K Sell
36,000
-14,000
-28% -$149K ﹤0.01% 787
2014
Q4 		$505K Buy
+50,000
New +$526K 0.01% 728

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HBK Investments's RDY Position: Q2 2017 in Review

HBK Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2017, closing a stake of 30,000 shares — an estimated $241K sold.

HBK Investments first reported a position in RDY in Q4 2014 and held it in 3 quarters. The position peaked at $505K in Q4 2014. 128 funds tracked by Wall St. Rank hold RDY as of Q2 2017.

  • HBK Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2017 after selling out during the quarter.
  • HBK Investments sold 30,000 Dr. Reddy's Laboratories shares in Q2 2017, an estimated $241K.
  • HBK Investments first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 3 quarters.
  • HBK Investments's Dr. Reddy's Laboratories position peaked at $505K in Q4 2014.
  • 128 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2017.

Based on HBK Investments's 13F filing for Q2 2017, filed 14 Aug 2017.